Teva announces launch of a first generic version of revlimid® (lenalidomide capsules), in the u.s.

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), announced today the launch of a first generic version of revlimid®1 (lenalidomide capsules), in 5mg, 10mg, 15mg, and 25mg strengths, in the united states. teva's lenalidomide capsules are a prescription medicine used in adults for the treatment of (1) multiple myeloma in combination with the medicine dexamethasone, (2) certain myelodysplastic
TEVA Ratings Summary
TEVA Quant Ranking